Pfizer Inc. (pfe)
PFE Valuation
| P/E (trailing) | 36.60 |
| P/E (forward) | 9.73 |
| EV/EBITDA | 8.38 |
| Price/Sales | 2.52 |
| Price/Book | 1.89 |
| Market cap | $160.62B |
Start Free — open PFE in Vest Terminal
Access live data, filings, ownership, and analysis for Pfizer Inc..
Pfizer Inc. FAQ
What does Pfizer Inc. (PFE) do?
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiova…
What is PFE's P/E ratio?
Pfizer Inc. has a trailing P/E of 36.60× based on publicly available market data.
Does PFE pay a dividend?
Indicated dividend yield: 6.2%. Confirm ex-dates and payout history in Vest Terminal.
What sector is PFE in?
Pfizer Inc. is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is PFE's market capitalization?
Approximate market cap: $160.62B.
What are the main risks for PFE?
Key risks include elevated valuation, among factors on this page.
What are the strengths of PFE?
Potential positives include gross margin of 74.7% supports competitive unit economics, positive free cash flow ($12.49b).
Where can I get analyst estimates for PFE?
Public analyst price targets and consensus for Pfizer Inc. are on the free /stocks/pfe/estimates page. Deeper estimate history and models are available in Vest Terminal.